Submit Deal

Naoki Okamura

President and CEO at ASTELLAS PHARMA INC

Manager

Deal Bio

Total Deals4

Valued Deals4

Total Value£7,231M

Avg. Deal Size£1,808M

Market Context

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

Expertise

Key Relationships (4)

Sort

United States

Biotechnology

AcquisitionPublicMajority

target

Audentes Therapeutics

bidder

Astellas Pharma

£2,318m

73 dealmakers

Japan

Pharmaceuticals

AcquisitionCross BorderMajorityPrivate

target

Products Rights For Five Legacy Products

bidder

Cheplapharm Arzneimittel Gbmh

£81m

5 dealmakers

United States

Biotechnology

Cross BorderMajorityPublicAcquisition

target

Iveric Bio

bidder

Astellas Pharma

£4,693m

22 dealmakers

United States

Pharmaceuticals

Cross BorderPrivateAcquisitionMajority

target

Propella Therapeutics

bidder

Astellas Pharma

£137m

41 dealmakers

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy